J
Jong Sung Kim
Publications - 1
Citations - 27
Jong Sung Kim is an academic researcher. The author has contributed to research in topics: Placebo-controlled study & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 15 citations.
Papers
More filters
Journal ArticleDOI
Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
Hugues Chabriat,Claudio L. Bassetti,Ute Marx,Marie-Laure Audoli-Inthavong,Aurore Sors,Estelle Lambert,Marine Wattez,Dirk M. Hermann,Katharina Althaus,Sergi Amaro,Hee-Joon Bae,Zbigniew Bak,Leonardo Barbarini,Pietro Bassi,Rodrigo Bazan,Daniel Bereczki,Tomasz Berkowicz,Joerg Berrouschot,Dylan Blacquiere,Waldemar Brola,Kenneth Butcher,Pere Cardona,Jae-Kwan Cha,Geoffrey Cloud,David Cohen,Charlotte Cordonnier,Attila Csanyi,Anna Członkowska,Stephen N. Davis,Jesse Dawson,Nina De Klippel,Christian Denier,Philippe Desfontaines,Hans-Christoph Diener,Peter Dioszeghy,Diederik Willem Dippel,Laura Dorado,Andras Folyovich,Gabriel Rodriguez Freitas,Maurício André Gheller Friedrich,Waldemar Fryze,Rubens José Gagliardi,Marianna Gottschal,Rohan Grimley,Martin Grond,Klaus Gröschel,Hassan Hosseini,Yangha Hwang,Bernd Kallmuenzer,Usman A. Khan,Jong Sung Kim,Timothy Kleinig,Agnes Koves,Aida Lago Martin,Anetta Lasek-Bal,Giuseppe Lembo,Robin Lemmens,Ralf Lindert,Luiz Carlos Porcello Marrone,Maite Martinez Zabaleta,Jean-Louis Mas,Jaime Masjuan Vallejo,Mikael Mazighi,Cesar Minelli,Amit K Mistri,Carlos A. Molina,Francisco Moniche Alvarez,Carla H.C. Moro,Wim M. Mulleners,D. G. Nabavi,Jean-Philippe Neau,Bill O'brien,Csaba Ovary,Gyula Panczel,Man Seok Park,Thanh G. Phan,Suzanne Ragab,Konrad Rejdak,Gabriel R. de Freitas,Christine Roffe,Jaume Roquer Gonzalez,Luisa Rover,Gisele Sampaio Silva,Peter D. Schellinger,Tomas Segura Martin,Louise Shaw,Igor Sibon,Ondrej Skoda,Didier Smadja,Piotr Sobolewski,Hassan Soda,Nikola Sprigg,Maciej Swiat,Laszlo Szapary,Norbert Szegedi,Danilo Toni,Attila Valikovics,Geert Vanhooren,László Vécsei,Theodore Wein,Andrew Wong,Alvaro Ximenez Carrillo +101 more
TL;DR: The Randomized Efficacy and Safety Trial of Oral GABAA α5 receptor antagonist S44819 after Recent ischemic Event (RESTORE BRAIN) aimed to evaluate the safety and efficacy of S 44819 for enhancing clinical recovery of patients with ischaemic stroke.